Federico Grossi
Director/Board Member chez Endoprotech, Inc.
Fortune : 6 M $ au 31/03/2024
Provenance du réseau au premier degré de Federico Grossi
| Entité | Type d'entité | Industrie | |
|---|---|---|---|
| Public Company | Pharmaceuticals: Major | 26 | |
Endoprotech, Inc.
 Endoprotech, Inc. Medical DistributorsDistribution Services Endoprotech, Inc. develops therapies for organ transplantation and invasive cardiovascular surgery. The company was founded on August 17, 2005 and is headquartered in Louisville, KY.
3
| Holding Company | Medical Distributors | 3 |
Potentia Pharmaceuticals, Inc.
 Potentia Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Potentia Pharmaceuticals, Inc. operates as a biotechnology company. It focuses on the development of novel therapeutics and drug delivery technologies to address chronic inflammatory diseases. The company was founded by Cedric Francois, David Darst, Alec Machiels and Pascal Deschatelets in 2001 and is headquartered in Crestwood, KY.
2
| Holding Company | Pharmaceuticals: Major | 2 |
Graphique Sociétés connectées au second degré
Relation dans plusieurs entreprises
Sociétés connectées à Federico Grossi via son réseau personnel
| Société | Secteur | Personnes liées | Poste principal |
|---|---|---|---|
| BIOGEN INC. | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal | |
| GELESIS INC | Biotechnology | Director of Finance/CFO Director/Board Member | |
Critical Biologics Corp.
 Critical Biologics Corp. Medical SpecialtiesHealth Technology Critical Biologics Corp. develops and commercializes diagnostics and therapeutics drugs. The firm focuses in the development of a theranostic platform to screen and treat both acute and chronic patients with low plasma gelsolin levels (hypogelsolinemia) at high risk of life-threatening complications. The company was founded by James W. Fordyce, Terence S. Russell, Shun Lee Po, and Thomas P. Stossel in 2006 and is headquartered in Cambridge, MA. | Medical Specialties | Director/Board Member | |
Serica Technologies, Inc.
 Serica Technologies, Inc. Pharmaceuticals: MajorHealth Technology Serica Technologies, Inc. produces silk-based biomaterial products for tissue rejuvenation. The company develops knee ligament replacements from silk biomaterial. The company was founded on May 31, 2000 and is headquartered in Irvine, CA. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
| ATEA PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Director of Finance/CFO Director/Board Member | |
Revon Systems, Inc.
 Revon Systems, Inc. Packaged SoftwareTechnology Services Revon Systems, Inc. operates a platform that connects physicians and patients for medicine. Its products include Revon Patient App, Revon Physician App, Alexa Skill and Research Coordinators Portal. The firm's platform’s digital interface supports data collection for the investigation of the performance of pharmaceutical and other interventions in various patient populations. It enables digital registry services, real world evidence collection and patient reported outcomes tracking for pharmaceutical and medical device companies conducting clinical trials. The company was founded by Cedric Francois and Pascal Deschatelets and is headquartered in Crestwood, KY. | Packaged Software | General Counsel Corporate Officer/Principal | |
| TURG POIN | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
Harvard University
 Harvard University Other Consumer ServicesConsumer Services Harvard University engages in the provision of teaching and research. It has twelve degree-granting Schools in addition to the Radcliffe Institute for Advanced Study, offering a global education. The university was founded in 1636 and is headquartered in Cambridge, MA. | College/University | Doctorate Degree Undergraduate Degree | |
| HANG LUNG GROUP LIMITED | Real Estate Development | Director/Board Member | |
Alcon Laboratories, Inc.
 Alcon Laboratories, Inc. Medical SpecialtiesHealth Technology Alcon Laboratories, Inc. develops and manufactures ophthalmic pharmaceutical products. The firm offers over-the-counter eye care products, medical devices, equipment, ophthalmic drugs, surgical instruments, needles, and sutures for microsurgery and disposable drapes. The company was founded by Robert Alexander and William Conner in 1945 and is headquartered in Fort Worth, TX. | Medical Specialties | Corporate Officer/Principal Corporate Officer/Principal | |
| University of California, Los Angeles | College/University | Graduate Degree | |
| Bentley University | College/University | Graduate Degree Undergraduate Degree | |
| Morningside College | College/University | Corporate Officer/Principal | |
| University of Toronto | College/University | Graduate Degree Doctorate Degree | |
| University of Louisville | College/University | Graduate Degree Corporate Officer/Principal Corporate Officer/Principal Undergraduate Degree | |
| University of Michigan | College/University | Masters Business Admin Doctorate Degree | |
Council on Foreign Relations, Inc.
 Council on Foreign Relations, Inc. Investment Trusts/Mutual FundsMiscellaneous Council on Foreign Relations, Inc. provides and disseminates ideas on foreign policies to individuals, corporate members, journalists and policy makers. It operates a forum for government officials, students and other interested parties to study and discuss world issues and impact on American foreign policies. The company publishes Foreign Affairs, a magazine that comes out six times a year, along with books and studies by its own scholars. Council on Foreign Relations was founded in 1921 and is headquartered in New York City, NY. | Investment Trusts/Mutual Funds | Director/Board Member | |
EMD Serono, Inc.
 EMD Serono, Inc. Pharmaceuticals: MajorHealth Technology EMD Serono, Inc. operates as a biopharmaceutical firm. The firm develops recombinant prescription medicines. Its therapies include neurology and immunology, metabolic endocrinology, fertility, and oncology. The company was founded in 1971 and is headquartered in Rockland, MA. | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal | |
Morningside Group Ltd.
 Morningside Group Ltd. Investment ManagersFinance Morningside Group (Morningside Group) is a venture capital and private equity firm founded in 1986 by Lok Chung Chan and Chi Chung Chan. The firm is headquartered in Hong Kong. | Investment Managers | Founder | |
| The Chinese University of Hong Kong | College/University | Chairman | |
| Fudan University | College/University | Undergraduate Degree Director/Board Member | |
New York Academy of Sciences
 New York Academy of Sciences Miscellaneous Commercial ServicesCommercial Services New York Academy of Sciences is an independent, not-for-profit organization, which engages in the advancement of scientific research, education, and policy. The company was founded in 1817 and is headquartered in New York, NY. | Miscellaneous Commercial Services | Corporate Officer/Principal | |
Massachusetts General Hospital Cancer Center
 Massachusetts General Hospital Cancer Center Hospital/Nursing ManagementHealth Services Massachusetts General Hospital Cancer Center operates as cancer treatment center. The company was founded by John Warren in 1811 and is headquartered in Boston, MA. | Hospital/Nursing Management | Corporate Officer/Principal | |
Oxyrane UK Ltd.
 Oxyrane UK Ltd. Pharmaceuticals: MajorHealth Technology Oxyrane UK Ltd. engages in the development of novel enzyme replacement therapies for lysosomal storage disorders. Its product is a pre-clinical ERT for Pompe Disease - a serious muscle disease - produced using engineered yeast cells. The firm develops recombinant enzyme products using a proprietary, engineered yeast expression platform based on Yarrowia lipolytica. The company was founded by Robin Kumar Mitra, Adriana L. Botes and Michael Campbell in 2006 and is headquartered in Manchester, the United Kingdom. | Pharmaceuticals: Major | Director/Board Member | |
MetaCure (USA), Inc.
 MetaCure (USA), Inc. Pharmaceuticals: MajorHealth Technology MetaCure (USA), Inc. engages in the development and commercialization of invasive treatment for diabetes. The company was founded by Shlomo Ben-Haim in 2003 and is headquartered in Orangeburg, NY. | Pharmaceuticals: Major | Director/Board Member | |
Advanced Cell Diagnostics, Inc.
 Advanced Cell Diagnostics, Inc. BiotechnologyHealth Technology Advanced Cell Diagnostics, Inc. operates as a biotechnology company. It specializes in the emerging field of molecular pathology and developing cell- and tissue-based diagnostic tests for personalized medicine. The company was founded by Lou Yuling and Steve Chan in 2006 and is headquartered in Newark, CA. | Biotechnology | Director/Board Member | |
MatriVAX, Inc.
 MatriVAX, Inc. Pharmaceuticals: MajorHealth Technology MatriVAX, Inc. operates as a biotechnology company. It develops technologies for simplified, low-cost production of vaccines against polysaccharide antigens from pathogenic bacteria. The company was founded by Yichen Lu and John Mekalanos in 2007 and is headquartered in Boston, MA. | Pharmaceuticals: Major | Director/Board Member | |
venBio Partners LLC
 venBio Partners LLC Investment ManagersFinance venBio Partners LLC (venBio) is a private equity subsidiary of Venbio Partners LP founded in 2009 by Adelman robert and Goodman corey. The firm is headquartered in San Francisco, California. | Investment Managers | Founder Private Equity Investor | |
| The International Society for Stem Cell Research | Corporate Officer/Principal | ||
| Morningside Foundation | Director/Board Member | ||
| NUCANA PLC | Biotechnology | Director/Board Member | |
Synchroneuron, Inc.
 Synchroneuron, Inc. Pharmaceuticals: MajorHealth Technology Synchroneuron, Inc. develops therapies for tardive dyskinesia (TD) and other neuropsychiatric disorders. It offers a novel treatment for movement disorders, utilizing a drug with simultaneous effects on excitatory and inhibitory neurotransmission. The company was founded by Kei-Lai L. Fong, William D. Kerns, Marc R. Cote and Barry S. Fogel in 2011 and is headquartered in Newton, MA. | Pharmaceuticals: Major | Director/Board Member | |
| The Wharton School of the University of Pennsylvania | College/University | Undergraduate Degree Masters Business Admin | |
| Harvard College | College/University | Undergraduate Degree Undergraduate Degree | |
InSilixa, Inc.
 InSilixa, Inc. SemiconductorsElectronic Technology Insilixa, Inc. develops molecular diagnostic platform. It offers CMOS biochips for microarray technology, qPCR, and DNA sequencing. The company was founded by Arun Manickam and Arjang Hassibi in 2012 and is headquartered in Sunnyvale, CA. | Semiconductors | Director/Board Member | |
PhoreMost Ltd.
 PhoreMost Ltd. Pharmaceuticals: MajorHealth Technology PhoreMost Ltd. operates as a drug discovery company. It engages in identifying new druggable targets for cancer and other unmet diseases. PhoreMost uses SiteSeeker technology, a live-cell phenotypic assay system that can identify unexpected, or cryptic druggable sites in specific disease driving targets and pathways that can?t be readily seen using conventional non-cell based analytical methods. The company was founded by Christopher John Torrance and Ashok Venkitaraman on April 1, 2014 and is headquartered in Cambridge, the United Kingdom. | Pharmaceuticals: Major | Director/Board Member | |
Vigeo Therapeutics, Inc.
 Vigeo Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Vigeo Therapeutics, Inc. manufactures cancer drugs. It develops therapies designed to reprogram the tumor immune microenvironment by targeting CD36 and CD47 via Tsp-1 induction. The company was founded by Randolph Watnick and Jing Watnick in 2011 and is headquartered in Cambridge, MA. | Pharmaceuticals: Major | Director of Finance/CFO Director/Board Member | |
| KEZAR LIFE SCIENCES, INC. | Biotechnology | Director/Board Member Director/Board Member | |
LumiraDx Ltd. (Cayman Islands)
 LumiraDx Ltd. (Cayman Islands) BiotechnologyHealth Technology LumiraDx UK Ltd. is a POC diagnostic company. The firm focuses on transforming community-based healthcare by providing critical diagnostic information to healthcare providers at the point of need, thereby enabling more informed medical decisions to improve health outcomes. It develops and launches platform, which is an integrated system comprised of a small, versatile Instrument, precise, low-cost microfluidic test strips, and seamless, secure digital connectivity. The company was founded by Ronald Zwanziger, Jerry McAleer and David Scott on September 5, 2014 and is headquartered in George Town, Cayman Islands. | Biotechnology | Director/Board Member | |
Canopy Education, Inc.
 Canopy Education, Inc. Miscellaneous Commercial ServicesCommercial Services Canopy Education, Inc. engages in the operation of a mentorship, test preparation and college consulting firm. It offers college and elite application programs, college essay assistance, school list creation and subject tutoring services. The company was founded by Zack Perkins, Johan Zhang, Mohan Zhang, and Vinay Bhaskara in 2013 and is headquartered in Cambridge, MA. | Miscellaneous Commercial Services | Director/Board Member Director/Board Member | |
Morningside Group Ltd. (United States)
 Morningside Group Ltd. (United States) Financial ConglomeratesFinance Part of Morningside Group Ltd., the private company is a biotechnology firm based in Newton Center, MA. The company provides innovative solutions for drug discovery and development, with a focus on cancer and rare diseases. Morningside Group Ltd. (United States) provides investment services. The company was founded by Gerald Chan. | Financial Conglomerates | Founder | |
| STEALTH BIOTHERAPEUTICS CORP | Biotechnology | Director of Finance/CFO Chairman | |
Apnimed, Inc.
 Apnimed, Inc. BiotechnologyHealth Technology Apnimed, Inc. operates as a clinical-stage company. It discovers novel pharmaceutical therapies for sleep apnea and related disorders. The company was founded by Lawrence G. Miller and Luigi Taranto Montemurro in 2017 and is headquartered in Cambridge, MA. | Biotechnology | Director of Finance/CFO Director/Board Member | |
Stealth BioTherapeutics, Inc.
 Stealth BioTherapeutics, Inc. Pharmaceuticals: MajorHealth Technology Part of Stealth BioTherapeutics Corp., Stealth BioTherapeutics, Inc. develops therapies to treat mitochondrial dysfunctions and age-related diseases. The private company is based in Newton, MA. The company was founded in 2007. Irene P. McCarthy has been the CEO of the company since 2009. | Pharmaceuticals: Major | Director/Board Member | |
Vesigen, Inc.
 Vesigen, Inc. BiotechnologyHealth Technology Vesigen, Inc. develops groundbreaking therapeutic products directed to intracellular targets using a scalable and extracellular vesicle delivery technology. The company is headquartered in Cambridge, MA. | Biotechnology | Chairman | |
| RAYZEBIO, INC. | Biotechnology | Director/Board Member Founder | |
Natural Polymer International Corp.
 Natural Polymer International Corp. Agricultural Commodities/MillingProcess Industries Natural Polymer International Corp. manufactures and markets pet products. Its services include product development, design and formulation, computer-aided design drawing, production mold and dies, temporary molds and dies, raw material sourcing, injection molding, extrusion, co-extrusion and cold-extrusion, packing, and display design. It products include N-bone, Twistix, and Get Naked. The company was founded by Scott Wang and Lok Chung Chan in 1996 and is headquartered Plano, TX. | Agricultural Commodities/Milling | Director/Board Member Founder |
Statistiques
Internationale
| Etats-Unis | 41 |
| Hong Kong | 4 |
| Royaume-Uni | 4 |
| Canada | 3 |
| Chine | 2 |
Sectorielle
| Health Technology | 26 |
| Consumer Services | 12 |
| Finance | 5 |
| Health Services | 3 |
| Commercial Services | 3 |
Opérationnelle
| Director/Board Member | 147 |
| Corporate Officer/Principal | 81 |
| Director of Finance/CFO | 47 |
| Independent Dir/Board Member | 36 |
| Undergraduate Degree | 24 |
Relations les plus connectées
| Insiders | |
|---|---|
| Daniel Geffken | 53 |
| Lok Chung Chan | 40 |
| Bihua Chen | 32 |
| Maha Katabi | 28 |
| Robert J. Adelman | 25 |
| Doug Onsi | 25 |
| Paul R. Fonteyne | 25 |
| Aaron Royston | 19 |
| Stephanie O'Brien | 18 |
| Marie-Claude Bernal | 11 |
| James Chopas | 10 |
| Timothy Sullivan | 8 |
| Steven Jon Axon | 8 |
| Sean Kuntz | 6 |
| David Watson | 6 |
- Bourse
- Insiders
- Federico Grossi
- Connexions Sociétés
